Clinical value of serum <scp>AFP</scp> and <scp>PIVKA‐II</scp> for diagnosis, treatment and prognosis of hepatocellular carcinoma

Abstract

Combined detection of AFP and PIVKA-II is superior to both tests alone. We found that higher serum level of PIVKA-II indicates more severe HCC, with worse prognosis, while the level of AFP had no correlation with the prognosis.